Cargando…

Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells

Glucagon-like peptide-1 receptor (GLP-1R) agonists are being used for the treatment of type 2 diabetes (T2D) and may have beneficial effects on the pancreatic β-cells. Here, we evaluated the effects of GLP-1R agonism on insulin secretory granule (ISG) dynamics in primary β-cells isolated from human...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri, Gianmarco, Tesi, Marta, Pesce, Luca, Bugliani, Marco, Grano, Francesca, Occhipinti, Margherita, Suleiman, Mara, De Luca, Carmela, Marselli, Lorella, Marchetti, Piero, Cardarelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464798/
https://www.ncbi.nlm.nih.gov/pubmed/34575477
http://dx.doi.org/10.3390/pharmaceutics13091403
_version_ 1784572706439561216
author Ferri, Gianmarco
Tesi, Marta
Pesce, Luca
Bugliani, Marco
Grano, Francesca
Occhipinti, Margherita
Suleiman, Mara
De Luca, Carmela
Marselli, Lorella
Marchetti, Piero
Cardarelli, Francesco
author_facet Ferri, Gianmarco
Tesi, Marta
Pesce, Luca
Bugliani, Marco
Grano, Francesca
Occhipinti, Margherita
Suleiman, Mara
De Luca, Carmela
Marselli, Lorella
Marchetti, Piero
Cardarelli, Francesco
author_sort Ferri, Gianmarco
collection PubMed
description Glucagon-like peptide-1 receptor (GLP-1R) agonists are being used for the treatment of type 2 diabetes (T2D) and may have beneficial effects on the pancreatic β-cells. Here, we evaluated the effects of GLP-1R agonism on insulin secretory granule (ISG) dynamics in primary β-cells isolated from human islets exposed to palmitate-induced lipotoxic stress. Islets cells were exposed for 48 h to 0.5 mM palmitate (hereafter, ‘Palm’) with or without the addition of a GLP-1 agonist, namely 10 nM exendin-4 (hereafter, ‘Ex-4’). Dissociated cells were first transfected with syncollin-EGFP in order to fluorescently mark the ISGs. Then, by applying a recently established spatiotemporal correlation spectroscopy technique, the average structural (i.e., size) and dynamic (i.e., the local diffusivity and mode of motion) properties of ISGs are extracted from a calculated imaging-derived Mean Square Displacement (iMSD) trace. Besides defining the structural/dynamic fingerprint of ISGs in human cells for the first time, iMSD analysis allowed to probe fingerprint variations under selected conditions: namely, it was shown that Palm affects ISGs dynamics in response to acute glucose stimulation by abolishing the ISGs mobilization typically imparted by glucose and, concomitantly, by reducing the extent of ISGs active/directed intracellular movement. By contrast, co-treatment with Ex-4 normalizes ISG dynamics, i.e., re-establish ISG mobilization and ability to perform active transport in response to glucose stimulation. These observations were correlated with standard glucose-stimulated insulin secretion (GSIS), which resulted in being reduced in cells exposed to Palm but preserved in cells concomitantly exposed to 10 nM Ex-4. Our data support the idea that GLP-1R agonism may exert its beneficial effect on human β-cells under metabolic stress by maintaining ISGs’ proper intracellular dynamics.
format Online
Article
Text
id pubmed-8464798
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84647982021-09-27 Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells Ferri, Gianmarco Tesi, Marta Pesce, Luca Bugliani, Marco Grano, Francesca Occhipinti, Margherita Suleiman, Mara De Luca, Carmela Marselli, Lorella Marchetti, Piero Cardarelli, Francesco Pharmaceutics Article Glucagon-like peptide-1 receptor (GLP-1R) agonists are being used for the treatment of type 2 diabetes (T2D) and may have beneficial effects on the pancreatic β-cells. Here, we evaluated the effects of GLP-1R agonism on insulin secretory granule (ISG) dynamics in primary β-cells isolated from human islets exposed to palmitate-induced lipotoxic stress. Islets cells were exposed for 48 h to 0.5 mM palmitate (hereafter, ‘Palm’) with or without the addition of a GLP-1 agonist, namely 10 nM exendin-4 (hereafter, ‘Ex-4’). Dissociated cells were first transfected with syncollin-EGFP in order to fluorescently mark the ISGs. Then, by applying a recently established spatiotemporal correlation spectroscopy technique, the average structural (i.e., size) and dynamic (i.e., the local diffusivity and mode of motion) properties of ISGs are extracted from a calculated imaging-derived Mean Square Displacement (iMSD) trace. Besides defining the structural/dynamic fingerprint of ISGs in human cells for the first time, iMSD analysis allowed to probe fingerprint variations under selected conditions: namely, it was shown that Palm affects ISGs dynamics in response to acute glucose stimulation by abolishing the ISGs mobilization typically imparted by glucose and, concomitantly, by reducing the extent of ISGs active/directed intracellular movement. By contrast, co-treatment with Ex-4 normalizes ISG dynamics, i.e., re-establish ISG mobilization and ability to perform active transport in response to glucose stimulation. These observations were correlated with standard glucose-stimulated insulin secretion (GSIS), which resulted in being reduced in cells exposed to Palm but preserved in cells concomitantly exposed to 10 nM Ex-4. Our data support the idea that GLP-1R agonism may exert its beneficial effect on human β-cells under metabolic stress by maintaining ISGs’ proper intracellular dynamics. MDPI 2021-09-03 /pmc/articles/PMC8464798/ /pubmed/34575477 http://dx.doi.org/10.3390/pharmaceutics13091403 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ferri, Gianmarco
Tesi, Marta
Pesce, Luca
Bugliani, Marco
Grano, Francesca
Occhipinti, Margherita
Suleiman, Mara
De Luca, Carmela
Marselli, Lorella
Marchetti, Piero
Cardarelli, Francesco
Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells
title Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells
title_full Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells
title_fullStr Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells
title_full_unstemmed Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells
title_short Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells
title_sort spatiotemporal correlation spectroscopy reveals a protective effect of peptide-based glp-1 receptor agonism against lipotoxicity on insulin granule dynamics in primary human β-cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464798/
https://www.ncbi.nlm.nih.gov/pubmed/34575477
http://dx.doi.org/10.3390/pharmaceutics13091403
work_keys_str_mv AT ferrigianmarco spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT tesimarta spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT pesceluca spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT buglianimarco spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT granofrancesca spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT occhipintimargherita spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT suleimanmara spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT delucacarmela spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT marsellilorella spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT marchettipiero spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells
AT cardarellifrancesco spatiotemporalcorrelationspectroscopyrevealsaprotectiveeffectofpeptidebasedglp1receptoragonismagainstlipotoxicityoninsulingranuledynamicsinprimaryhumanbcells